Breast Cancer Chemotherapy Can Be Administered Safely During the COVID‐19 Pandemic

In a retrospective analysis, breast cancer chemotherapy did not increase the risk of SARS‐CoV‐2 infection or death following infection, suggesting it can be administered safely during the COVID‐19 pandemic.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Conference Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262310/
https://www.ncbi.nlm.nih.gov/pubmed/34173299
http://dx.doi.org/10.1002/onco.13876
Descripción
Sumario:In a retrospective analysis, breast cancer chemotherapy did not increase the risk of SARS‐CoV‐2 infection or death following infection, suggesting it can be administered safely during the COVID‐19 pandemic.

Ejemplares similares